eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Draft Guidance for Industry on "Incorporation of Physical-Chemical Identifiers into Solid Oral Dosage Form Drug Products for Anticounterfeiting," Availability

Draft Guidance for Industry on "Incorporation of Physical-Chemical Identifiers into Solid Oral Dosage Form Drug Products for Anticounterfeiting," Availability

Document ID: FDA-2009-D-0212-0001
Document Type: Notice
Agency: Food And Drug Administration
Topics: No Topics associated with this document
Federal Register Number: E9-16612
View Document:  View as format pdf View as format html

Details Information

Document Subtype: NAD-Notice of Availability of Data
Received Date: July 13 2009, at 01:09 PM Eastern Daylight Time
Start-End Page: 34021 - 34022
Page Count: 2
Comment Start Date: July 14 2009, at 12:00 AM Eastern Standard Time
Comment Due Date: October 13 2009, at 11:59 PM Eastern Standard Time

Comments

    View All
Total: 14
Merck & Co., Inc. - Comment
Posted: 10/06/2009     ID: FDA-2009-D-0212-0004

Oct 13,2009 11:59 PM ET
GlaxoSmithKline - Comment
Posted: 10/09/2009     ID: FDA-2009-D-0212-0006

Oct 13,2009 11:59 PM ET
InfraTrac, Inc. - Comment
Posted: 10/15/2009     ID: FDA-2009-D-0212-0007

Oct 13,2009 11:59 PM ET
United States Pharmacopeial Convention (USP) - Comment
Posted: 10/15/2009     ID: FDA-2009-D-0212-0008

Oct 13,2009 11:59 PM ET
NanoGuardian, division of NanoInk, Inc. - Comment
Posted: 10/15/2009     ID: FDA-2009-D-0212-0011

Oct 13,2009 11:59 PM ET

Related Documents

Total: 0
No documents available.